BIRMINGHAM, Mich., May 18, 2020 /PRNewswire/ -- MacuHealth LLC would like to congratulate Dr Paul Bernstein and the Bernstein Laboratory for their recent publication in PNAS https://www.ncbi.nlm.nih.gov/pubmed/32409609
Singapore - A study by co-author John Nolan, PhD, of the Macular Pigment Research Group at Waterford Institute of Technology and presented at the 18th International Symposium on Carotenoids in Lucerne, Switzerland, showed that the addition of (RS) meso-zeaxanthin, a non-dietary carotenoid found in many eye health supplements, contributes no additional efficacy for eye health in people with non-advanced age-related macular degeneration (early AMD). The findings from the Central Retinal Enrichment Supplementation Trials (CREST) add doubt to the need for supplement formulations containing (RS) meso-zeaxanthin.